This supplement to the original EPIC4AD plasma proteomics predictive biomarkers project will enable full genotyping of the cohort for genetic data and, for a subset of the cohort, DNA methylation profiling for epigenetic data. The resulting combination of proteomics, genetics, epigenetics, clinical profile and lifestyle information will provide a rich and multifactorial profile from which to derive patterns predictive of future clinical outcome.